ATE194753T1 - Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist - Google Patents
Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonistInfo
- Publication number
- ATE194753T1 ATE194753T1 AT92907704T AT92907704T ATE194753T1 AT E194753 T1 ATE194753 T1 AT E194753T1 AT 92907704 T AT92907704 T AT 92907704T AT 92907704 T AT92907704 T AT 92907704T AT E194753 T1 ATE194753 T1 AT E194753T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antagonist
- movement disorder
- opiator
- modulating
- hyperkinetic movement
- Prior art date
Links
- 208000000269 Hyperkinesis Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 239000003401 opiate antagonist Substances 0.000 abstract 2
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 230000001107 psychogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66054391A | 1991-02-25 | 1991-02-25 | |
| PCT/US1992/001418 WO1992014364A1 (en) | 1991-02-25 | 1992-02-25 | Opiate receptor antagonist modulates hyperkinetic movement disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE194753T1 true ATE194753T1 (de) | 2000-08-15 |
Family
ID=24649948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92907704T ATE194753T1 (de) | 1991-02-25 | 1992-02-25 | Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6153620A (de) |
| EP (1) | EP0573565B1 (de) |
| JP (1) | JPH06505747A (de) |
| AT (1) | ATE194753T1 (de) |
| AU (1) | AU658401B2 (de) |
| CA (1) | CA2104229C (de) |
| DE (1) | DE69231274T2 (de) |
| ES (1) | ES2148174T3 (de) |
| WO (1) | WO1992014364A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9815618D0 (en) * | 1998-07-18 | 1998-09-16 | Univ Manchester | Treatment of dyskinesia |
| EP1615646B2 (de) | 2003-04-08 | 2022-07-27 | Progenics Pharmaceuticals, Inc. | Pharmazeutische formulierungen mit methylnaltrexon |
| US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| CN104248763A (zh) | 2005-03-07 | 2014-12-31 | 芝加哥大学 | 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途 |
| US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
| AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
| AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
| TWI489984B (zh) | 2006-08-04 | 2015-07-01 | Wyeth Corp | 用於非經腸道傳輸化合物之配方及其用途 |
| CA2682125C (en) | 2007-03-29 | 2015-06-16 | Progenics Pharmaceuticals, Inc. | Peripheral opioid receptor antagonists and uses thereof |
| CA2682129A1 (en) | 2007-03-29 | 2008-10-09 | Progenics Pharmaceuticals, Inc. | Crystal forms and uses thereof |
| JP5469593B2 (ja) | 2007-03-29 | 2014-04-16 | ワイス・エルエルシー | 末梢性オピオイド受容体アンタゴニストおよびその使用 |
| US8796301B2 (en) | 2007-04-24 | 2014-08-05 | Toray Industries, Inc. | Therapeutic or prophylactic agent for dyskinesia |
| WO2009052072A1 (en) * | 2007-10-18 | 2009-04-23 | Allergan, Inc. | Treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione |
| JP5358587B2 (ja) | 2008-02-06 | 2013-12-04 | プロジェニックス・ファーマシューティカルス・インコーポレイテッド | （ｒ），（ｒ）−２，２’−ビス−メチルナルトレキソンの製造及び用途 |
| JP5647098B2 (ja) | 2008-03-21 | 2014-12-24 | ザ ユニヴァーシティー オヴ シカゴ | オピオイド拮抗薬とｍＴＯＲ阻害薬を用いた治療 |
| CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
| GB2543271A (en) * | 2015-10-12 | 2017-04-19 | Lars Holger Hermann Dr | Products for treating psychogenic pain disorders |
-
1992
- 1992-02-25 EP EP92907704A patent/EP0573565B1/de not_active Expired - Lifetime
- 1992-02-25 DE DE69231274T patent/DE69231274T2/de not_active Expired - Fee Related
- 1992-02-25 CA CA002104229A patent/CA2104229C/en not_active Expired - Fee Related
- 1992-02-25 AT AT92907704T patent/ATE194753T1/de not_active IP Right Cessation
- 1992-02-25 JP JP4507357A patent/JPH06505747A/ja active Pending
- 1992-02-25 WO PCT/US1992/001418 patent/WO1992014364A1/en not_active Ceased
- 1992-02-25 AU AU14563/92A patent/AU658401B2/en not_active Ceased
- 1992-02-25 ES ES92907704T patent/ES2148174T3/es not_active Expired - Lifetime
-
1993
- 1993-01-21 US US08/006,691 patent/US6153620A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0573565B1 (de) | 2000-07-19 |
| CA2104229C (en) | 1997-04-15 |
| ES2148174T3 (es) | 2000-10-16 |
| CA2104229A1 (en) | 1992-08-26 |
| DE69231274T2 (de) | 2000-11-30 |
| AU658401B2 (en) | 1995-04-13 |
| DE69231274D1 (de) | 2000-08-24 |
| EP0573565A1 (de) | 1993-12-15 |
| EP0573565A4 (de) | 1994-03-18 |
| WO1992014364A1 (en) | 1992-09-03 |
| US6153620A (en) | 2000-11-28 |
| AU1456392A (en) | 1992-09-15 |
| JPH06505747A (ja) | 1994-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE194753T1 (de) | Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist | |
| MY107158A (en) | 3-arylcarbonyl; -1h-indoles useful as therapeutic agents. | |
| NO960630D0 (no) | Heterocykler anvendelige som neurokinin antagonister | |
| MX9802383A (es) | Derivados de pirimidina como antagonistas del receptor 5ht26. | |
| SE9003665D0 (sv) | Morphine prodrugs | |
| MX9800125A (es) | Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor. | |
| ATE279517T1 (de) | Il-17 receptor | |
| DZ1763A1 (fr) | Composition vaccinantes. | |
| NO305603B1 (no) | 2,6-diaminopurin-derivater, anvendelse derav samt farmas°ytisk blanding | |
| ES2125377T3 (es) | Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina. | |
| BG101194A (en) | New heteroaryl oxazolidinons | |
| EA200100022A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
| EP0691037A4 (de) | Elektrochemisches fullerensystem | |
| TR199700834T1 (xx) | 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�. | |
| AU2759892A (en) | N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
| YU48915B (sh) | Sulfonilkarbamid i postupak za njegovo dobijanje | |
| DE69201906D1 (de) | Zylinderbüchse. | |
| DE69202890D1 (de) | Zylinderlaufbüchse. | |
| FI922346A7 (fi) | Muscarinreceptorantagonister. | |
| SE9401596D0 (sv) | New compounds | |
| FR2684398B1 (fr) | Composition bitumineuse phosphorescente. | |
| YU48719B (sh) | Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida | |
| NO981188D0 (no) | 5-HT3-reseptorantagonister for dyskinesi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |